Medline ® Abstract for Reference 41
of 'Systemic therapy for advanced non-small cell lung cancer with an activating mutation in the epidermal growth factor receptor'
MET amplification (amp) as a resistance mechanism to osimertinib
Piotrowska Z, Thress KS, Mooradian M, et al
J Clin Oncol. 2017;35S(15):ASCO #9020.